261 related articles for article (PubMed ID: 26637267)
21. Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.
Monsees GM; Kraft P; Chanock SJ; Hunter DJ; Han J
Breast Cancer Res Treat; 2011 Jan; 125(1):207-14. PubMed ID: 20496165
[TBL] [Abstract][Full Text] [Related]
22. Downstream targets of GWAS-detected genes for breast, lung, and prostate and colon cancer converge to G1/S transition pathway.
Gorlova OY; Demidenko EI; Amos CI; Gorlov IP
Hum Mol Genet; 2017 Apr; 26(8):1465-1471. PubMed ID: 28334950
[TBL] [Abstract][Full Text] [Related]
23. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population.
Luo H; Li Z; Qing Y; Zhang SH; Peng Y; Li Q; Wang D
Asian Pac J Cancer Prev; 2014; 15(3):1133-40. PubMed ID: 24606430
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
[TBL] [Abstract][Full Text] [Related]
27. Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.
Chu LW; Meyer TE; Li Q; Menashe I; Yu K; Rosenberg PS; Huang WY; Quraishi SM; Kaaks R; Weiss JM; Hayes RB; Chanock SJ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1848-54. PubMed ID: 20551303
[TBL] [Abstract][Full Text] [Related]
28. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Gdowicz-Klosok A; Widel M; Rzeszowska-Wolny J
Mutat Res; 2013 Jul; 755(1):42-8. PubMed ID: 23669291
[TBL] [Abstract][Full Text] [Related]
29. Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Lu HM; Li S; Black MH; Lee S; Hoiness R; Wu S; Mu W; Huether R; Chen J; Sridhar S; Tian Y; McFarland R; Dolinsky J; Tippin Davis B; Mexal S; Dunlop C; Elliott A
JAMA Oncol; 2019 Jan; 5(1):51-57. PubMed ID: 30128536
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women.
Romanowicz-Makowska H; Smolarz B; Zadrozny M; Westfal B; Baszczynski J; Polac I; Sporny S
Tohoku J Exp Med; 2011 Jul; 224(3):201-8. PubMed ID: 21701125
[TBL] [Abstract][Full Text] [Related]
32. Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium.
Wang M; Liu H; Liu Z; Yi X; Bickeboller H; Hung RJ; Brennan P; Landi MT; Caporaso N; Christiani DC; Doherty JA; ; Amos CI; Wei Q
Carcinogenesis; 2016 Sep; 37(9):888-896. PubMed ID: 27288692
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
34. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.
Michiels S; Danoy P; Dessen P; Bera A; Boulet T; Bouchardy C; Lathrop M; Sarasin A; Benhamou S
Carcinogenesis; 2007 Aug; 28(8):1731-9. PubMed ID: 17494052
[TBL] [Abstract][Full Text] [Related]
36. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
[TBL] [Abstract][Full Text] [Related]
37. Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.
Qian DC; Byun J; Han Y; Greene CS; Field JK; Hung RJ; Brhane Y; Mclaughlin JR; Fehringer G; Landi MT; Rosenberger A; Bickeböller H; Malhotra J; Risch A; Heinrich J; Hunter DJ; Henderson BE; Haiman CA; Schumacher FR; Eeles RA; Easton DF; Seminara D; Amos CI
Hum Mol Genet; 2015 Dec; 24(25):7406-20. PubMed ID: 26483192
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
39. Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer.
Matejcic M; Shaban HA; Quintana MW; Schumacher FR; Edlund CK; Naghi L; Pai RK; Haile RW; Levine AJ; Buchanan DD; Jenkins MA; Figueiredo JC; Rennert G; Gruber SB; Li L; Casey G; Conti DV; Schmit SL
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):895-903. PubMed ID: 33627384
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
